AR078688A1 - Disposicion de control para la generacion de ondas de defibrilacion, de carga automaticamente compensada, sin medicion de impedancia del paciente - Google Patents

Disposicion de control para la generacion de ondas de defibrilacion, de carga automaticamente compensada, sin medicion de impedancia del paciente

Info

Publication number
AR078688A1
AR078688A1 ARP090100645A AR078688A1 AR 078688 A1 AR078688 A1 AR 078688A1 AR P090100645 A ARP090100645 A AR P090100645A AR 078688 A1 AR078688 A1 AR 078688A1
Authority
AR
Argentina
Prior art keywords
load
waves
generation
patient
defibrillation
Prior art date
Application number
Other languages
English (en)
Original Assignee
Andrade Eduardo Javier
Carranza Gustavo Ernesto
Andrade Marcelo Gabriel
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Andrade Eduardo Javier, Carranza Gustavo Ernesto, Andrade Marcelo Gabriel filed Critical Andrade Eduardo Javier
Priority to ARP090100645 priority Critical patent/AR078688A1/es
Priority to JP2010037437A priority patent/JP2010194318A/ja
Priority to EP10154339A priority patent/EP2229978A1/en
Publication of AR078688A1 publication Critical patent/AR078688A1/es

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61NELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00Electrotherapy; Circuits therefor
    • A61N1/18Applying electric currents by contact electrodes
    • A61N1/32Applying electric currents by contact electrodes alternating or intermittent currents
    • A61N1/38Applying electric currents by contact electrodes alternating or intermittent currents for producing shock effects
    • A61N1/39Heart defibrillators
    • A61N1/3906Heart defibrillators characterised by the form of the shockwave
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61NELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00Electrotherapy; Circuits therefor
    • A61N1/18Applying electric currents by contact electrodes
    • A61N1/32Applying electric currents by contact electrodes alternating or intermittent currents
    • A61N1/38Applying electric currents by contact electrodes alternating or intermittent currents for producing shock effects
    • A61N1/39Heart defibrillators
    • A61N1/3906Heart defibrillators characterised by the form of the shockwave
    • A61N1/3912Output circuitry therefor, e.g. switches
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61NELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00Electrotherapy; Circuits therefor
    • A61N1/18Applying electric currents by contact electrodes
    • A61N1/32Applying electric currents by contact electrodes alternating or intermittent currents
    • A61N1/38Applying electric currents by contact electrodes alternating or intermittent currents for producing shock effects
    • A61N1/39Heart defibrillators
    • A61N1/3925Monitoring; Protecting
    • A61N1/3937Monitoring output parameters
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61NELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00Electrotherapy; Circuits therefor
    • A61N1/18Applying electric currents by contact electrodes
    • A61N1/32Applying electric currents by contact electrodes alternating or intermittent currents
    • A61N1/38Applying electric currents by contact electrodes alternating or intermittent currents for producing shock effects
    • A61N1/39Heart defibrillators
    • A61N1/3975Power supply
    • A61N1/3981High voltage charging circuitry

Abstract

La solicitud que se revela describe un sistema para controlar la generacion de ondas de defibrilacion bifásicas, cuya principal característica es la de eliminar la necesidad de medir la impedancia del paciente. Esta simplificacion se logra al entregar la carga en pulsos y hacer esta carga proporcional a la carga instantánea remanente en el capacitor de almacenamiento al fin de cada pulso o ciclo de muestreo. Para esto se compara la carga entregada al paciente (integral de la corriente) con una fraccion de la tension presente en el capacitor, anulando la corriente en el instante en que la integral de la corriente alcanza el valor de dicha fraccion. De esta manera la carga en fase positiva y la carga en fase negativa resultan exclusivamente funcion de la dosis seleccionada (energía o carga segun se prefiera) y constantes para diferentes valores de impedancia de paciente, y la tension necesaria en el capacitor resulta exclusivamente funcion de la dosis seleccionada.
ARP090100645 2009-02-25 2009-02-25 Disposicion de control para la generacion de ondas de defibrilacion, de carga automaticamente compensada, sin medicion de impedancia del paciente AR078688A1 (es)

Priority Applications (3)

Application Number Priority Date Filing Date Title
ARP090100645 AR078688A1 (es) 2009-02-25 2009-02-25 Disposicion de control para la generacion de ondas de defibrilacion, de carga automaticamente compensada, sin medicion de impedancia del paciente
JP2010037437A JP2010194318A (ja) 2009-02-25 2010-02-23 電荷の除細動波形を生成する制御システム
EP10154339A EP2229978A1 (en) 2009-02-25 2010-02-23 A control system to generate defibrillation waves of automatically compensated charge without measurement of the patient impedance

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ARP090100645 AR078688A1 (es) 2009-02-25 2009-02-25 Disposicion de control para la generacion de ondas de defibrilacion, de carga automaticamente compensada, sin medicion de impedancia del paciente

Publications (1)

Publication Number Publication Date
AR078688A1 true AR078688A1 (es) 2011-11-30

Family

ID=42283590

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP090100645 AR078688A1 (es) 2009-02-25 2009-02-25 Disposicion de control para la generacion de ondas de defibrilacion, de carga automaticamente compensada, sin medicion de impedancia del paciente

Country Status (3)

Country Link
EP (1) EP2229978A1 (es)
JP (1) JP2010194318A (es)
AR (1) AR078688A1 (es)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101049172B1 (ko) 2011-05-06 2011-07-14 주식회사 씨유메디칼시스템 제세동기의 자동 위상변환 제어장치
CN103146750B (zh) * 2013-03-18 2014-11-26 四川大学 电转染的方法及设备
KR101690603B1 (ko) 2015-08-27 2017-01-13 (주)라디안 래더 브릿지 회로를 포함하는 제세동기
US10946207B2 (en) 2017-05-27 2021-03-16 West Affum Holdings Corp. Defibrillation waveforms for a wearable cardiac defibrillator

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5593427A (en) * 1993-08-06 1997-01-14 Heartstream, Inc. Electrotherapy method
US5824017A (en) 1997-03-05 1998-10-20 Physio-Control Corporation H-bridge circuit for generating a high-energy biphasic waveform in an external defibrillator
JPH10307135A (ja) 1997-05-02 1998-11-17 Toa Medical Electronics Co Ltd 赤血球形態異常の検出方法
US6208896B1 (en) 1998-11-13 2001-03-27 Agilent Technologies, Inc. Method and apparatus for providing variable defibrillation waveforms using switch-mode amplification
FR2788699B1 (fr) 1999-01-27 2001-05-25 Bruker Medical Sa Impulsions ou serie d'impulsions de defibrillation et dispositif pour les generer
US6647290B2 (en) 2000-01-18 2003-11-11 Koninklijke Philips Electronics N.V. Charge-based defibrillation method and apparatus
FR2879937B1 (fr) * 2004-12-23 2008-01-11 Schiller Medical Sas Defibrillateur dont le circuit de decharge est securise et comporte un pont en h
US7398122B1 (en) 2005-04-07 2008-07-08 Pacesetter, Inc. Self adjusting optimal waveforms
US7283871B1 (en) 2005-04-07 2007-10-16 Pacesetter, Inc. Self adjusting optimal waveforms

Also Published As

Publication number Publication date
EP2229978A1 (en) 2010-09-22
JP2010194318A (ja) 2010-09-09

Similar Documents

Publication Publication Date Title
ATLAS Collaboration atlas. publications@ cern. ch et al. Improved luminosity determination in pp collisions at s=7\mathrmTeV using the ATLAS detector at the LHC
Aad et al. Measurement of the W boson polarization in top quark decays with the ATLAS detector
AR078688A1 (es) Disposicion de control para la generacion de ondas de defibrilacion, de carga automaticamente compensada, sin medicion de impedancia del paciente
Aad et al. Search for quark contact interactions in dijet angular distributions in pp collisions at s= 7 TeV measured with the ATLAS detector
BR112015002933A2 (pt) dispositivo implantável para uso no corpo humano e/ou animal para substituir uma válvula de um órgão.
CL2014001515A1 (es) Uso de dexmedetomidina o una sal de ella para tratar o prevenir el dolor sin sedacion importante tal como dolor idiopatico; y dispositivo de dosis medida que comprende una composicion farmaceutica con dexmedetomidina.
BR112014030060A2 (pt) compostos de tetra-hidropirazolopirimidina
UY33369A (es) Heterociclilbencil-pirazoles sustituidos y su uso
MY187233A (en) Drospirenone-based contraceptive for a female patient affected with excess weight
AR099833A1 (es) Compuesto amídico como antagonista del receptor ep4
AR093220A1 (es) Dispositivo de irradiacion de una composicion tipo pasta
Efe et al. The CMS barrel calorimeter response to particle beams from 2 to 350 GeV/c
BR112014026344A2 (pt) métodos para aumentar eficiência do ato de engolir
ES2570583T3 (es) Procedimiento para el control del peso de los animales
Zakirova et al. Case report of application gene construction with VEGF and BMP2 in restoration of tear in the anterior cruciate ligament of a large breed dog
Fiedler et al. Local SAR elevations in the human head induced by high-permittivity pads at 7 Tesla
BR112015010471A2 (pt) dispensador dobrável, de uso único para uma composição adesiva de tratamento de vaso sanitário
BR112014022687A8 (pt) uso de uma quantidade eficaz de r-p88 ou um sal farmaceuticamente aceitável do mesmo, ou um éster do mesmo ou um sal farmaceuticamente aceitável de um éster do mesmo, composição farmacêutica, r-p88 ou um sal farmaceuticamente aceitável do mesmo, ou um éster do mesmo ou um sal farmaceuticamente aceitável de um éster do mesmo
PE20130812A1 (es) Combinacion de inhibidor de xantina oxidasa y antagonistas del receptor de angiotensina ii
Arft Micro-multiformity and Tradition: Clues to the Odyssey’s Composition
Rodgers et al. Human cardiac T1 mapping in vivo at 7T: quantifying and correcting for partial inversion
Ahmed Histopathological effects of exogenous melatonin on connective tissues of thymus gland in male rats
Slobodin Glutamate antagonists in treatment and rehabilitation of patients with postherpetic neuralgia
Tamosiuniene et al. C28 SEX, DRUGS, AND PULMONARY HYPERTENSION: Immunodeficiency Mediate The Gender Dimorphism In Pulmonary Hypertension
PL420206A1 (pl) Nowe zastosowanie kwasu kynureninowego w celu zredukowania przyrostu masy ciała

Legal Events

Date Code Title Description
FG Grant; registration